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Abstract
Objectives—evaluate if CT features of intra-diverticular bladder cancer can predict clinical 
outcome.
Methods—retrospective study of 34 patients with intra-diverticular bladder cancer. Two 
radiologists independently evaluated all CT exams.
Results—CT tumor length and width were significantly associated with survival for both readers 
(HRs 1.31–1.62, p<0.001–0.043). No other tumor features were significantly associated with 
survival. The inter-reader agreement for the assessment of CT features was fair to substantial 
(k=0.34–0.78; CCC=0.56–0.66). There was no association between TUR pathology stage and 
survival (HR 2.10; p=0.21).
Conclusions—In patients with intra-diverticular bladder cancer, the tumor length and width 
measured on the pre-treatment CT predicted survival.
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INTRODUCTION
Bladder diverticula are defined as outpouchings of the urothelial lining through the 
muscularis layer of the bladder wall. They may result from congenital weakness of the 
bladder wall at the level of the ureterovesical junction (e.g. Hutch’s diverticulum) or may be 
acquired as a result of increased intravesical pressure, typically in the context of lower 
urinary tract obstruction.
Bladder diverticula may sometimes harbor tumors, classically thought to be secondary to 
urinary stasis with chronic infection and inflammation leading to metaplasia and subsequent 
tumor formation. However, the transitional cell lining of a diverticulum is identical to that 
which covers the entire urinary drainage system, and therefore carcinogenic alteration 
related to exposure of urinary agents can similarly affect the lining of the diverticulum 
predisposing to cancer formation. Although diverticular tumors account for only about 1.5% 
of all bladder cancers (1), they pose distinct challenges for diagnosis and management and 
warrant special attention. First, although direct visualization of the bladder lumen through 
cystoscopy has been demonstrated to be an adequate first-line method for the diagnosis of 
bladder neoplasms, cystoscopic visualization of diverticular tumors may be difficult, 
particularly if the diverticula have narrow orifices or are otherwise difficult to access. 
Furthermore, diverticula are characterized by absence or thin muscularis propria layer, 
which increases the risk of perforation during biopsy or transurethral resection (TUR) and 
also theoretically facilitates extra-vesical tumor spread (2). Attempts to avoid perforation 
and tumor cell dissemination during biopsy often lead to understaging on TUR.
The role of imaging for the evaluation of intra-diverticular tumors is not well known since 
prior studies have been limited to case reports and small case series (3–11). Therefore, the 
purpose of this study was to describe the computed tomography (CT) features of intra-
diverticular bladder cancer and evaluate if the imaging features can predict clinical outcome
MATERIALS AND METHODS
Patients
This retrospective study was compliant with the Health Insurance Portability and 
Accountability Act. The institutional review board issued a waiver of informed consent. The 
inclusion criteria for the study were: (i) cystoscopy-guided biopsy or resection of intra-
diverticular bladder tumor performed between 2001 and 2010 at our institution; (ii) CT 
imaging performed before treatment; (iii) CT imaging study available in DICOM format 
through our institution’s picture archiving and communications system (PACS) and (iv) 
complete histopathology report available. Of 106 patients treated for intra-diverticular 
bladder tumors at our institution during the study period, 35 satisfied all the above inclusion 
criteria. One patient was excluded because of severe beam-hardening artifacts on CT caused 
by bilateral hip prosthesis. Thus, our final study population consisted of 34 patients. Clinical 
and demographic characteristics are presented in Table 1.
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CT acquisition
All CT imaging studies were performed on commercially available 16- or 64-detector-row 
CT scanners (GE Medical Systems, Toshiba, Philips) using the following scan parameters: 
tube voltage, 120KVp; tube current time product, 80–442 mAs; reconstruction slice 
thickness, 2.5–7.5 mm; pitch 0.75–1.75. Iodinated intravenous contrast material was 
administered in 32 of 34 (91%) of patients.
CT interpretation
Two radiologists retrospectively and independently reviewed all CT studies using a PACS 
workstation (Centricity; GE Medical System). Reader 1 (--; omitted for blinded review) had 
6 years of experience in interpreting genitourinary CT studies, and reader 2 (--; omitted for 
blinded review) had 2 years of experience in interpreting CT studies. Both readers were 
aware that all patients had bladder cancer, but they were otherwise blinded to all clinical and 
histopathological findings as well as the original CT imaging reports. Both readers assessed 
the CT images for the following:
I. total number of bladder diverticula with tumors;
II. tumor involvement of the diverticular neck (connecting the diverticulum to the 
bladder lumen) (Fig 1);
III. tumor length (defined as the length of contact between the tumor and the 
diverticular wall) and the largest tumor diameter perpendicular to the tumor length 
(tumor width) (Fig 2);
IV. tumor morphology (i.e., flat vs. polypoid) (Fig 3).
V. presence of extravesical tumor spread
Clinical and Histopathologic Data
TUR tumor histology was established according to the 2004 World Health Organization 
histological classification of tumors of the urinary tract (12). Cystectomy pathology tumor 
stages were recorded according to TNM stage (13). All patients were initially biopsied via 
TUR. Definitive treatment was at the discretion of the treating physician and consisted of 
TUR alone in 29% (10/34), TUR followed by intravesical Bacillus Calmette-Guerin (BCG) 
therapy in 18% (6/34), partial cystectomy in 15% (5/34) and radical cystectomy in 38% 
(13/34). Experienced genitourinary pathologists, who process all bladder cancer specimens 
at our institution, performed histopathologic analyses.
Statistical Analysis
Continuous variables were expressed as medians and ranges, categorical variables as 
percentages and frequencies. Two-sided p-values ≤ 0.05 were considered to indicate 
statistical significance. All statistical analyses were performed using commercially available 
software (SAS 9.2, SAS Institute, Cary, NC).
Inter-reader agreement levels for categorical variables were calculated using Cohen’s 
Kappa. For continuous variables, the concordance correlation coefficient (CCC) was used. 
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Inter-reader agreement values were interpreted as follows: 0.01–0.20: slight agreement; 
0.21–0.40: fair agreement; 0.41–0.60: moderate agreement; 0.61–0.80: substantial 
agreement; 0.81–1.0: almost perfect agreement.
Survival analysis was performed for TUR pathology stage and CT features separately for 
each reader. When more than 1 diverticular tumor was present in a single patient (which 
occurred in 3 of the 34 cases), the largest tumor was used for all calculations. Overall 
survival (OS) was calculated as the interval from the time of the CT to the time of death or 
last follow-up. Cox regression was used to examine the associations between CT features 
with OS, with a robust covariance matrix and an independent correlation structure to take 
into account multiple diverticula per patient. Hazard ratios (HR) and 95% confidence 
intervals were estimated for every feature.
RESULTS
Clinical and Pathological Evaluation
Clinical staging confirmed a total of 37 intra-diverticular bladder cancers in 34 patients. 
Tumor histologies were obtained by transurethral biopsy in all cases and consisted of 
transitional cell carcinoma in 26 patients, mixed transitional and squamous cell carcinoma in 
3, neuroendocrine carcinoma in 2, squamous cell carcinoma in 1, adenocarcinoma in 1, and 
sarcomatoid carcinoma in 1 patient (Table 1). Eighteen (53%) patients underwent partial/
radical cystectomy. In 8 of these 18 patients (44%), the tumor stage assigned on pathological 
review of the cystectomy specimen was higher than the clinical stage. In seven of these 18 
patients (39%), extravesical extension was identified in the cystectomy specimen. The 
treatments received by all patients are summarized in Table 1. The mean follow-up for all 
patients was 1060 days (range, 11–2540 days).
CT features and inter-reader agreement
Reader 1 (R1) identified 28 tumors in 49 bladder diverticula and reader 2 (R2) identified 39 
tumors in 51 bladder diverticula. Tumor involvement of the diverticular neck was identified 
in 15 patients (53.5%) by R1 and in 25 patients (64.1%) by R2. Tumor morphology was 
polypoid in 60.7% (17/28) and flat in 39.2% (11/28) of tumors according to R1, and 
polypoid in 46.1% (18/39) and flat in 53.8% (21/39) according to R2. Median tumor length 
was 23.5 mm (range, 3–78 mm) for R1 and 18.5 mm (range, 3–72 mm) for R2. Median 
tumor width was 14 mm (range, 2–71 mm) for R1 and 9 mm (range, 2–72 mm) for R2 
(Table 2). Inter-reader agreement levels, also summarized in Table 2, ranged from fair to 
substantial (k=0.34–0.78; CCC=0.56–0.66). Of the 7 patients in whom extravesical 
extension was present on pathological analysis of the cystectomy specimen, extravesical 
extension on CT was identified in 6/7 (86%) patients by R1 and 5/7 patients (71%) by R2.
Associations between TUR pathology, CT features and survival
During the follow-up period, 22/34 (65%) patients remained alive and 12/34 (35%) patients 
died. There was no association between TUR pathology stage and survival (HR 2.10; 
p=0.21). On CT, the length of contact between the tumor and the diverticular wall correlated 
significantly with overall survival for both readers (HR 1.45, p=0.007 for R1 and HR=1.55; 
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p<0.001 for R2). In addition, tumor depth correlated significantly with overall survival for 
both readers (HR=1.62; p<0.001 for R1 and HR=1.31; p=0.043 for R2). Associations 
between CT features and survival are summarized in Table 3.
DISCUSSION
In this study we identified two CT features--namely, tumor width and the length of contact 
between the tumor and the diverticular wall--that were associated with survival and could 
serve as prognostic indicators in patients with intra-diverticular bladder tumors. This 
information is clinically relevant, as the pathology stage from the transurethral resection 
specimen, which is typically considered to guide treatment decisions in these patients, 
provided limited prognostic information in our study population (i.e. there was no 
association between TUR pathology stage and survival).
Literature regarding the use of imaging in intra-diverticular bladder tumors is limited and 
consists predominantly of case reports or small case series (3–11, 14–17). Our study 
population (n=34) is larger than the sum of patients included in all of the prior studies (3–11, 
14–17), none of which correlated imaging findings with clinical outcomes. Some of the 
earlier reports evaluated the role of intravenous pyelography (IVP) (3)(6), a technique that 
was found to be of limited value and is no longer in routine clinical use. Other case series 
have shown that cross-sectional imaging with CT and magnetic resonance imaging (MRI) 
offer incremental value compared to IVP and cystography for the evaluation of intra-
diverticular tumors. Dondalski et al. evaluated 6 patients with diverticular bladder tumors 
who underwent IVP/cystography and cross-sectional imaging (5 with CT and 1 with MRI) 
(4). Only 3 of the 6 tumors were seen as intraluminal filling defects on IVP/cystography. In 
one patient, CT showed a concentric tumor at the diverticular neck, with corresponding IVP/
cystography showing only smooth narrowing in the same area. In a large diverticulum, CT 
and MRI showed a tumor that was not visualized on cystography due to obstruction at the 
diverticular orifice. Another study found that CT was able to document the absence of 
extravesical extension in all 5 patients in whom CT was performed for preoperative staging 
of intra-diverticular bladder tumors (5). Haecker et al. reported one case of intra-diverticular 
bladder tumor that was detected on both CT and endorectal ultrasound but was not detected 
on transabdominal ultrasound (7). Another case report described how a large pelvic mass 
detected on CT was characterized as a diverticular bladder tumor using multiplanar T2-
weighted MRI (8).
The majority of patients (32 of 34) in our study were men, and most patients in our study (29 
of 34) had either pure or mixed transitional cell carcinomas. In addition, the tumors of most 
patients demonstrated invasive (22 of 34) and/or high-grade (31 of 34) features on 
pathology. These clinical and demographic characteristics of our patient population are 
similar to those reported in the largest clinical series published to date, which included 39 
patients (2), suggesting that our findings are relevant to all patients with intra-diverticular 
bladder tumors rather than only a specific subset of patients undergoing imaging. Although 
as mentioned earlier, it is difficult to estimate the prevalence of bladder diverticula in the 
general population, bladder diverticula should be considered potential sites of carcinoma and 
as such should be carefully evaluated, particularly in older patients with hematuria.
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Our study was limited by its retrospective design and small sample size. Despite a prior 
report suggesting significant associations between pathology stage of intra-diverticular 
bladder tumors and 5-year survival (2), we did not attempt to correlate the final pathology 
stage obtained from cystectomy with clinical outcomes in our patient population. Although 
all patients in our study had histologically confirmed tumors, only 18 patients underwent 
cystectomy. Upstaging of 8 and the presence of extravesical tumor extension in 7 of the 18 
patients who underwent cystectomy confirmed that, as expected, TUR tends to 
underestimate tumor extent in patients with intra-diverticular bladder tumors.
In addition, the study period was long (2001–2010) and thus the imaging protocols, 
including the CT scanners and acquisition parameters used, were heterogeneous. Modern 
imaging techniques using magnetic resonance imaging may play an expanded role in the 
assessment of these tumors; however at present there is no published data to support this. 
Given the rarity of intra-diverticular tumors it was felt that maximizing the sample size was 
desirable and that it was necessary to include all patients who had undergone pretreatment 
CT regardless of the technical parameters used. Another important limitation is the fact that 
readers were aware that all patients in the study had intra-diverticular bladder tumors. This 
may have influenced the readers’ confidence in establishing the presence of intra-
diverticular tumors, so that findings that would otherwise have been considered 
indeterminate or even normal may have been deemed suspicious.
In summary, in patients with intra-diverticular bladder tumors, the length of contact between 
the tumor and diverticular wall and the tumor width are significantly associated with overall 
survival.
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Figure 1. 
Male age 53 years. CT urography scan shows a large soft tissue mass involving the 
diverticulum neck and right lateral wall of the bladder. The mass extends into the 
extravesical fat (arrows). The patient was found to have transitional cell carcinoma with 
sarcomatoid features, stage T3.
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Figure 2. 
Male age 66 years. Delayed CT scan showing an irregular polypoid soft tissue mass (arrow) 
within a diverticulum without transmural invasion. There is circumferential thickening of 
the left bladder wall involving the diverticulum neck (asterisk). Lines show the length of 
contact between the tumor and the diverticular wall (l) and the tumor depth perpendicular to 
diverticular wall (d). The patient was found to have transitional cell carcinoma, stage T1.
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Figure 3. 
Female age 56 years. (a) Post-contrast and (b) delayed CT scans show a small polypoid 
tumor (arrow) within a postero-lateral diverticulum. The tumor is confined to the wall of the 
diverticulum. The patient was found to have transitional cell carcinoma, stage T1.
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Table 1
Patient Characteristics
Age in years, mean (range) 67 (42–87)
Gender, (%) n
 Male 94% (32/34)
 Female 6% (2/34)
Time between CT and cystoscopy in days, mean (range) 27 (0–169)
Number of intra-diverticular tumors per patient, (%)n
1 tumor (91%) 31/34
2 tumors (9%) 3/34
Clinical stage*, (%) n
Non-invasive (<T1) 35% (12/34)
Invasive (≥ T1) 65% (22/34)
Grade, (%) n
Low 9% (3/34)
High 91% (31/34)
Tumor Histology, (%) n
Transitional cell carcinoma 76% (26/34)
Mixed transitional and squamous cell 9% (3/34)
Neuroendocrine carcinoma 6% (2/34)
Squamous cell carcinoma 3% (1/34)
Adenocarcinoma 3% (1/34)
Sarcomatoid carcinoma 3% (1/34)
Presenting Complaint, (%) n
Hematuria 85% (29/34)
Treatment received, (%) n
TUR alone 29% (10/34)
TUR + intravesical BCG 18%(6/34)
TUR + Cystectomy 53%(18/34)
Abbreviations: TUR: Transurethral resection. BCG: Bacillus Calmette-Guerin
*Clinical stage based on physical exam, cystoscopy findings and pathological evaluation of transurethral resection specimen
Clin Imaging. Author manuscript; available in PMC 2016 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Di Paolo et al. Page 12
Ta
bl
e 
2
CT
 fe
at
ur
es
 a
nd
 in
te
rre
ad
er
 a
gr
ee
m
en
t
R
ea
de
r 
1
R
ea
de
r 
2
In
te
r-
R
ea
de
r 
A
gr
ee
m
en
t
Pa
tie
nt
In
tr
a-
D
iv
er
tic
ul
ar
 T
um
or
N
o
18
%
 (6
/34
)
6%
(2/
34
)
κ =
 
0.
45
2 
(0.
03
0, 
0.8
74
)
Y
es
82
%
(28
/34
)
94
%
(32
/34
)
N
um
be
r o
f I
nt
ra
-D
iv
er
tic
ul
ar
 T
um
or
s p
er
 p
at
ie
nt
N
o 
Tu
m
or
18
%
(6/
34
)
6%
(2/
34
)
κ =
 
0.
34
4 
(0.
12
9, 
0.5
59
)
1 
Tu
m
or
82
%
(28
/34
)
74
%
(25
/34
)
2 
Tu
m
or
s
n
o
n
e
21
%
(7/
34
)
Tu
m
or
D
iv
er
tic
ul
ar
 N
ec
k 
In
vo
lv
em
en
t*
N
o
46
%
(13
/28
)
36
%
(14
/39
)
κ =
 
0.
63
5 
(0.
42
2, 
0.8
71
)
Y
es
54
%
(15
/28
)
64
%
(25
/39
)
Tu
m
or
 m
or
ph
ol
og
y*
Po
ly
po
id
61
%
(17
/28
)
46
%
(18
/39
)
κ =
 
0.
77
9 
(0.
60
7, 
1.0
00
)
Fl
at
39
%
(11
/28
)
54
%
(21
/39
)
Tu
m
or
 W
id
th
 (m
m)
*
M
ed
ia
n 
(R
an
ge
)
14
 (2
–7
1)
9 
(2–
72
)
CC
C 
= 
0.
66
6 
(0.
12
4, 
0.9
64
)
Tu
m
or
 L
en
gt
h 
(m
m)
*
23
.5
 (3
–7
8)
18
.5
 (3
–7
2)
CC
C 
= 
0.
56
2 
(0.
14
7, 
0.8
64
)
C
T 
fe
at
ur
es
 (3
4 p
at
ie
nt
s;
 4
9 
di
ve
rti
cu
la
 fo
r r
ea
de
r 1
, 5
1 
di
ve
rti
cu
la
 fo
r r
ea
de
r 2
)
*
Fo
r d
iv
er
tic
ul
ar
 tu
m
or
s o
bs
er
ve
d 
on
 C
T 
sc
an
s.
κ:
 K
ap
pa
 (9
5%
 C
I);
 co
nc
ord
an
ce
 co
rre
lat
ion
 co
eff
ici
en
t: C
CC
 (9
5%
CI
)
Clin Imaging. Author manuscript; available in PMC 2016 January 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Di Paolo et al. Page 13
Ta
bl
e 
3
A
ss
oc
ia
tio
ns
 b
et
w
ee
n 
CT
 fe
at
ur
es
 a
nd
 su
rv
iv
al
 (O
S =
 ov
era
ll s
urv
iva
l, P
FS
 = 
pro
gre
ssi
on
-fr
ee
 su
rvi
va
l)
C
T 
Fe
at
ur
e
R
ea
de
r 
1
R
ea
de
r 
2
O
S
O
S
H
R
 (9
5%
CI
)
p-
va
lu
e
H
R
 (9
5%
CI
)
p-
va
lu
e
Tu
m
or
 p
re
se
nc
e
N
o
1
N
o 
ev
en
t f
or
 p
at
ie
nt
s w
ith
 n
o 
tu
m
or
 o
n 
CT
, H
R 
no
t e
sti
m
ab
le
 (N
E)
.
Y
es
3.
95
 (0
.51
, 3
0.5
)
0.
18
8
N
um
be
r o
f d
iv
er
tic
ul
a 
w
ith
 tu
m
or
0
1
N
E
1
3.
95
 (0
.51
, 3
0.5
)
0.
18
8
1
2
N
E
1.
09
 (0
.30
, 3
.98
)
0.
89
7
M
or
ph
ol
og
y
Po
ly
po
id
1
1
Fl
at
0.
36
 (0
.12
, 1
.12
)
0.
07
7
0.
35
 (0
.13
, 0
.93
)
0.
03
6
D
iv
er
tic
ul
ar
 n
ec
k 
in
vo
lv
em
en
t
N
o
1
1
Y
es
1.
64
 (0
.74
, 3
.61
)
0.
22
1
1.
20
 (0
.51
, 2
.84
)
0.
67
1
Tu
m
or
 le
ng
th
1.
45
 (1
.11
, 1
.90
)
0.
00
7
1.
55
 (1
.22
, 1
.97
)
<
.0
01
Tu
m
or
 w
id
th
1.
62
 (1
.29
, 2
.03
)
<
.0
01
1.
31
 (1
.01
, 1
.71
)
0.
04
3
N
ot
e:
 O
S=
 o
ve
ra
ll 
su
rv
iv
al
. H
R=
 h
az
ar
ds
 ra
tio
. P
-v
al
ue
s i
n 
bo
ld
 fo
nt
 in
di
ca
te
 st
at
ist
ic
al
ly
 si
gn
ifi
ca
nt
 a
ss
oc
ia
tio
ns
.
Clin Imaging. Author manuscript; available in PMC 2016 January 01.
